Each temperature change stresses the peptide structure
Several compounding pharmacies filed a lawsuit arguing the FDA had skipped legally required steps
Follow the prescribed schedule and do not increase the dose or frequency without medical guidance
Debris was not included in the analysis
Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort
Key Improvements Over GHK-CU When to Choose SRCP Over GHK-CU SRCP formulations excel in specific situations where first-generation copper peptides fall short